Oxford BioDynamics(DE:LMQ)
€0.01+0.00 (+20.00%)
DE:LMQ
Oxford BioDynamics financials statements
€0.01
At close:+0.00 (+20.00%)
Oxford BioDynamics (LMQ) Income Statement
1 Followers
Oxford BioDynamics Income Statement
Last quarter (Q2 2026), Oxford BioDynamics's total revenue was £687.00K, an increase of 110.09% from the same quarter last year. In Q2, Oxford BioDynamics's net income was £-4.46M. See Oxford BioDynamics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| £ 1.09M | £ 636.00K | £ 510.00K | £ 154.00K | £ 341.00K | |
| £ -6.15M | £ 289.00K | £ 266.00K | £ 116.00K | £ -557.00K | |
| £ 4.51M | £ 13.18M | £ 10.43M | £ 8.72M | £ 6.96M | |
| Depreciation and Amortization | £ 1.20M | £ 1.47M | £ 1.36M | £ 1.21M | £ 1.09M |
| £ -9.80M | £ -10.27M | £ -9.84M | £ -6.16M | £ -6.43M | |
| £ -10.66M | £ -12.89M | £ -11.03M | £ -8.60M | £ -7.51M | |
| £ -759.00K | £ 938.00K | £ -416.00K | £ 1.03M | £ -117.00K | |
| £ -11.42M | £ -11.96M | £ -11.41M | £ -7.57M | £ -7.63M | |
| £ -11.15M | £ -11.57M | £ -10.83M | £ -6.71M | £ -6.68M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.01 | £ -0.05 | £ -0.07 | £ -0.07 | £ -0.07 |
| Diluted EPS | £ -0.01 | £ -0.05 | £ -0.07 | £ -0.07 | £ -0.07 |
| Weighted Average Shares Outstanding | 1.39B | 255.73M | 147.48M | 99.70M | 92.56M |
| Weighted Average Shares Outstanding (Diluted) | 1.39B | 255.73M | 147.48M | 99.70M | 92.56M |
Currency in GBP
